CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 11, 2021-- bluebird bio, Inc. (Nasdaq: BLUE) announced its intent to separate its severe genetic disease and...
oncology
Cambridge-primarily based Agios Pharmaceuticals Inc. explained Monday it has agreed to provide its oncology business to Boston’s Servier Prescription drugs...
